4-Bromotoluene

We are 4-Bromotoluene CAS:106-38-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  4-Bromotoluene
CAS.NO:106-38-7
Synonyms:   4-Bromotoluene
p-Bromotoluene
Benzene, 1-bromo-4-methyl-
1-bromo-4-methylbenzene
 
Molecular Formula:C7H7Br
Molecular Weight:171.03400
 
Physical and Chemical Properties:
Density:1.39 g/mL at 25 °C(lit.)
Boiling point:184 °C(lit.)
Melting point:26-29 °C(lit.)
Flash point:185 °F
Index of Refraction:1.549
 
Specification:
Appearance:Colorless or light yellow liquid
Purity:≥99.0%
 
Packing:25kg/drum, can also be packaged according to customer requirements
Storage:The warehouse is ventilated and dried at low temperature, and stored and transported separately from oxidants and food materials.
Application:4-Bromotoluene is used as a reagent in the preparation of aromatic diselenides which are useful for generating anticancer lead compounds.

4-Bromotoluene


Related News: GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.1,5-Naphthalene diisocyanate CAS:3173-72-6 GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.5-formil-2,4-dimetil-1H-pirrol-3-carboxilato de etilo CAS:2199-59-9 Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).366821-62-7 Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).

Related Products
Product Name
2,6-Dichloronicotinic acid View Details
5-benzylsulfanyl-1,3,4-thiadiazol-2-amine View Details
Antioxidant PDDP View Details
Perchloromethylmercaptan manufacturer 2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile manufacturer 2-Bromo-3-fluorotoluene manufacturer 2-Bromo-4-fluoroanisole manufacturer Ethyl 2,3-dicyanopropanoate manufacturer